Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
Gynecologic Oncology
|
November 27, 2020
An increase in multi-site practices: The shifting paradigm for gynecologic cancer care delivery
Katherine Hicks-Courant, Genevieve P Kanter, Robert L Giuntoli, et al.
The Lancet. Oncology
|
December 25, 2012
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
John Farley, William E Brady, Vinod Vathipadiekal, et al.
Gynecologic Oncology Reports
|
March 4, 2022
Disparities in cancer-specific and overall survival in black women with endometrial cancer: A Medicare-SEER study
Daniel H Saris, Anna Jo Bodurtha Smith, Colleen Brensinger, et al.
JCI Insight
|
February 23, 2018
Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12
Mireia Uribe-Herranz, Kyle Bittinger, Stavros Rafail, et al.
Cancer Immunology, Immunotherapy : CII
|
October 25, 2011
Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission
Christina S Chu, Jean Boyer, Daniel S Schullery, et al.
Gynecologic Oncology
|
October 4, 2016
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study
Peter G Rose, James J Java, Mark A Morgan, et al.
Gynecologic Oncology
|
June 9, 2019
A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer
Kathleen N Moore, Camille C Gunderson, Paul Sabbatini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 7, 2022
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)
Janos L Tanyi, Leslie M Randall, Setsuko K Chambers, et al.
JCI Insight
|
June 22, 2023
H2Bub1 loss is an early contributor to clear cell ovarian cancer progression
Adam J Ferrari, Priyanka Rawat, Hannah S Rendulich, et al.
Cancer Cell
|
October 10, 2018
Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers
Jiao Yuan, Zhongyi Hu, Brandon A Mahal, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
Gynecologic Oncology
|
November 27, 2020
An increase in multi-site practices: The shifting paradigm for gynecologic cancer care delivery
Katherine Hicks-Courant, Genevieve P Kanter, Robert L Giuntoli, et al.
The Lancet. Oncology
|
December 25, 2012
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
John Farley, William E Brady, Vinod Vathipadiekal, et al.
Gynecologic Oncology Reports
|
March 4, 2022
Disparities in cancer-specific and overall survival in black women with endometrial cancer: A Medicare-SEER study
Daniel H Saris, Anna Jo Bodurtha Smith, Colleen Brensinger, et al.
JCI Insight
|
February 23, 2018
Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12
Mireia Uribe-Herranz, Kyle Bittinger, Stavros Rafail, et al.
Cancer Immunology, Immunotherapy : CII
|
October 25, 2011
Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission
Christina S Chu, Jean Boyer, Daniel S Schullery, et al.
Gynecologic Oncology
|
October 4, 2016
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study
Peter G Rose, James J Java, Mark A Morgan, et al.
Gynecologic Oncology
|
June 9, 2019
A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer
Kathleen N Moore, Camille C Gunderson, Paul Sabbatini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 7, 2022
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)
Janos L Tanyi, Leslie M Randall, Setsuko K Chambers, et al.
JCI Insight
|
June 22, 2023
H2Bub1 loss is an early contributor to clear cell ovarian cancer progression
Adam J Ferrari, Priyanka Rawat, Hannah S Rendulich, et al.
Cancer Cell
|
October 10, 2018
Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers
Jiao Yuan, Zhongyi Hu, Brandon A Mahal, et al.
Page
of 9